Literature DB >> 8789449

Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids.

D R Dunbar1, P A Moonie, M Zeviani, I J Holt.   

Abstract

143B.206 rho degrees cells were repopulated with mitochondria from a MELAS patient harbouring a mixture of 3243G:C and 3243A:T mitochondrial DNA. A number of biochemical assays were performed on selected cybrids with various proportions of the two types of mitochondrial DNA. These assays revealed a marked decrease in oxygen consumption with pyruvate, a complex I substrate, in cybrids containing 60% to 90% 3243G:C mitochondrial DNA. Moreover, these cybrids showed decreased synthesis of a number of polypeptides in a mitochondrial in vitro translation assay. A cybrid line with a very high level of 3243G:C mitochondrial DNA (95%) had additional deficiencies in complexes III and IV and there was a marked generalised decrease in mitochondrial translation in this cybrid. The observation of complex I deficiency is consistent with previously reported enzymatic measurements of muscle homogenates from MELAS patients with the 3243G:C mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789449     DOI: 10.1093/hmg/5.1.123

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Authors:  Steve E Durham; David C Samuels; Lynsey M Cree; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

2.  In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells.

Authors:  G Villani; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 3.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 4.  Modification of the wobble uridine in bacterial and mitochondrial tRNAs reading NNA/NNG triplets of 2-codon boxes.

Authors:  M Eugenia Armengod; Salvador Meseguer; Magda Villarroya; Silvia Prado; Ismaïl Moukadiri; Rafael Ruiz-Partida; M José Garzón; Carmen Navarro-González; Ana Martínez-Zamora
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function.

Authors:  P B M de Andrade; B Rubi; F Frigerio; J M W van den Ouweland; J A Maassen; P Maechler
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

6.  Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.

Authors:  Stjepana Kovac; Elisavet Preza; Henry Houlden; Matthew C Walker; Andrey Y Abramov
Journal:  Mol Neurobiol       Date:  2018-04-27       Impact factor: 5.590

Review 7.  Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.

Authors:  Russell H Swerdlow
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes.

Authors:  Ronghua Li; Min-Xin Guan
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

9.  Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.

Authors:  Yohei Kirino; Takehiro Yasukawa; Shigeo Ohta; Shigeo Akira; Kaisuke Ishihara; Kimitsuna Watanabe; Tsutomu Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

10.  Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Hyejeong Park; Edgar Davidson; Michael P King
Journal:  RNA       Date:  2008-09-16       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.